Search clinical trials for: Thalassemia intermedia

Total 1538 results

Mayo Clinic
National Cancer Institute (NCI)

Recruiting

MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Intermediate Grade Prostate Cancer

Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

Diffuse Large B-Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Transformed Non-Hodgkin Lymphoma

United States
The Hospital for Sick Children
Thalassemia Foundation of Canada

Recruiting

Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia

Thalassemia in Children

Canada
University of Louisville
National Eye Institute (NEI)

Recruiting

Intermediate Visual Space Perception

Vision

United States
AstraZeneca

Recruiting

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies (CERTIS1)

Advanced Solid Malignancies

United States, Korea, Republic of, Spain, Australia, Sweden, Germany, United Kingdom
Universitair Ziekenhuis Brussel

Recruiting

Autologous Testicular Tissue Transplantation

Hematologic Diseases | Cancer | Sickle Cell Thalassemia

Belgium
Rutgers, The State University of New Jersey

Recruiting

One-month Latent Tuberculosis Treatment for Renal Transplant Candidates

End Stage Renal Disease | Latent Tuberculosis | Renal Transplant Candidate for Right Kidney | Renal Transplant Candidate for Left Kidney

United States
Novo Nordisk A/S

Recruiting

Research Study Investigating How Well NDec Works in People With Sickle Cell Disease (ASCENT1)

Sickle Cell Disease

Spain, United States, United Kingdom, Canada, Italy, India, Turkey, Greece, South Africa, France, Lebanon, Oman
Shanghai Zhongshan Hospital
First People's Hospital of Hangzhou; RenJi Hospital; Huashan Hospital; Chengdu... and other collaborators

Recruiting

This Study is a Prospective, Multi-center, Real World, Observational Study, Which Aims at Evaluating Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease.

Peripheral Arterial Disease

China
Assiut University

Not yet recruiting

The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals

Beta-Thalassemia
University Hospital, Grenoble

Not yet recruiting

Screening Of CoRonary ArTEry diSease (SOCRATES)

Coronary Artery Disease | Cardiology
University College London Hospitals

Recruiting

Neurophysiologic Assessment of ET Patients Treated by Vim DBS

Essential Tremor

United Kingdom
Erasmus Medical Center

Recruiting

A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer (UPRATE)

Prostate Cancer

Netherlands
National Cancer Institute (NCI)

Recruiting

T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy

Cancer Of Prostate

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia

Sickle Cell Anemia | Beta Thalassemia

United States
Hangzhou Zede Pharma-Tech Co., Ltd.

Recruiting

Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients

Iron Overload | Thalassemia

China
Vertex Pharmaceuticals Incorporated
CRISPR Therapeutics

Recruiting

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)

Hematologic Diseases | Genetic Diseases, Inborn | Hemoglobinopathies | Thalassemia | Beta-Thalassemia

United States, Germany, Italy, United Kingdom, Canada
Institut Bergonié
Bayer

Recruiting

Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer (DARIUS)

Prostate Cancer

France
Weill Medical College of Cornell University

Recruiting

Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) (RTIRE)

Prostate Cancer

United States
University Hospital, Basel, Switzerland

Recruiting

Association of Intraoperative Blood Pressure Excursions Below Cerebral Autoregulatory Boundaries With Organ Injury Following Major Noncardiac Surgery (AR-NONCARDIAC)

Intraoperative Arterial Hypotension

Switzerland
Benha University

Recruiting

Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases

Pars Planitis | Central Serous Chorioretinopathy | Cystoid Macular Edema | Irvine-Gass Syndrome

Egypt
Zhongda Hospital

Recruiting

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC (CHANCE2202)

Hepatocellular Carcinoma

China
Swiss Federal Institute of Technology
Mahidol University

Not yet recruiting

Inhibitory Effect of a Polyphenol Supplement on Dietary Iron Absorption in Adults With Thalassemia

Iron Overload | Thalassemia

Thailand
Assiut University

Not yet recruiting

Study on the Effect of Different Risk Factors on the Growth Parameters of Thalassemic Patients in Assiut (AUCH)

Thalassemia Major
Genentech, Inc.

Recruiting

An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration (HONU)

Age-Related Macular Degeneration

France, Germany, Israel, United States, Australia, Puerto Rico, Italy
Sunnybrook Health Sciences Centre

Recruiting

A Phase II Trial of Intermediate Radiation Dose For Lymphoma

Follicular Lymphoma

Canada
Cairo University

Recruiting

Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate Cancer

Prostate Cancer

Egypt
Lawson Health Research Institute

Recruiting

PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER) (ARGOS/CLIMBER)

Prostate Cancer

Canada
Kasr El Aini Hospital

Not yet recruiting

Efficiency of Tadalafil for Management of Female Sexual Dysfunction

Sexual Dysfunction

Egypt
University Hospital, Geneva

Recruiting

Risk of CYP2C19 Phenoconversion in Healthy Volunteers With Rapid, Normal, and Intermediate Predicted Metabolizers' Status (Switch19)

Healthy

Switzerland
Centre Hospitalier Universitaire de Nice
Jazz Pharmaceuticals; Acute Leukemia French Association

Recruiting

CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics (ALFA2101)

Acute Myeloid Leukemia

France
New York Medical College

Recruiting

Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma (RADICAL)

Hodgkin Lymphoma | Non-hodgkin Lymphoma

United States
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC

Hepatocellular Carcinoma

China
XIANG YANQUN

Recruiting

PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | T2-3N0 or T1-2N1 | EBV-DNA≤4000 Copy/ml

China
University Hospital, Bordeaux

Recruiting

Treatment Pause Versus Treatment Continuation in IMDC Good or Intermediate Risk With Only One Adverse Prognostic Factor in mRCC Patients With an Objective Response at 12 Months of Treatment With PD1/ PDL1 ICIs + VEGFR-Tyrosine Kinase Inhibitors (SPICI)

Metastatic Renal Cell Carcinoma | Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score

France
Sun Yat-sen University

Recruiting

TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver Cancer

Hepatocellular Carcinoma

China
Center for Eye Research Australia
AlphaRET Pty Ltd.

Recruiting

Subthreshold Laser Treatment in Intermediate Age-related Macular Degeneration With Nascent Geographic Atrophy Study (LIANA)

Age-Related Macular Degeneration

Australia
Luzerner Kantonsspital

Recruiting

Preoperative Smoking Cessation in Patients Undergoing Surgery (PORTICO)

Smoking | Smoking Cessation | Postoperative Complications | Cancer | Head and Neck Cancer | Gynecologic Cancer | Smoking Reduction | Surgery | Surgery--Complications | Thoracic Cancer | Abdominal Cancer | Urologic Cancer | Perioperative Complication

Switzerland
The First Affiliated Hospital of Soochow University

Recruiting

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

AML | MDS | Old Age; Debility | Hematologic Cancer

China
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer

Prostate Cancer

United States
Mansoura University

Recruiting

Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial

Bladder Cancer

Egypt
UConn Health

Recruiting

Transitioning Emotionally and Academically to Middle School Successfully (TEAMSS) (TEAMSS)

Anxiety Disorders

United States
Novo Nordisk A/S

Recruiting

A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors (Explorer10)

Haemophilia A and B With and Without Inhibitors

United States, Spain, Italy, Estonia, Thailand, Canada, India, Malaysia, United Kingdom, Turkey, South Africa, Lebanon, Bosnia and Herzegovina, Bulgaria, France, Greece, Japan, Lithuania, Norway, Poland, Romania, Russian Federation, Swede... and more
Helios Health Institute GmbH
Heart Center Leipzig - University Hospital

Recruiting

Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis (CHOICE-FR)

Coronary Artery Stenosis | Transcatheter Aortic Valve Implantation

Germany
Assiut University

Recruiting

The Prevelence of HBB c.93-21 G-A in β Thalassemia Patients

Beta-Thalassemia

Egypt
Beijing Immunochina Medical Science & Technology...

Not yet recruiting

Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors

Melanoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma

China
Assiut University

Not yet recruiting

Assessment of Cognitive Functions, Psychological Symptoms, and Quality of Life Among B Thalassemia Patients and Their Clinical Correlates.

B Thalassemia
Ottawa Hospital Research Institute

Recruiting

Ozurdex Monotherapy Trial (OM)

Panuveitis | Uveitis, Posterior | Uveitis, Intermediate

Canada
Centre Hospitalier Universitaire Dijon

Not yet recruiting

Neuromuscular Deconditioning and Reconditioning in Colon Cancer Patients: an APA Muscle Rendorcement Program (REMUSCLON)

Colon Cancer | Muscle Strengthening

France
Pacific Edge Limited

Recruiting

CxBladder Surveillance of Intermediate and High-Risk Bladder Cancer Patients

Urothelial Bladder Cancer

United States

Search clinical trials for: Thalassemia intermedia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations